Summary unavailable.

Questions

Question 1

Which class of antiemetic drugs acts on the chemoreceptor trigger zone to inhibit nausea and vomiting?

View answer and explanation
Question 2

Which group of drugs is used almost exclusively to prevent motion sickness?

View answer and explanation
Question 3

How does metoclopramide primarily reduce nausea and vomiting?

View answer and explanation
Question 4

Dolasetron, granisetron, and ondansetron belong to a class of antiemetics that block the effects of serotonin at which receptor sites?

View answer and explanation
Question 5

Aprepitant, fosaprepitant, and rolapitant are used specifically for nausea and vomiting associated with what condition?

View answer and explanation
Question 6

Aprepitant and its related drugs act as selective antagonists at which receptors in the brain?

View answer and explanation
Question 7

What is the primary contraindication for the use of antiemetics according to the text?

View answer and explanation
Question 8

In which patient population should phenothiazines be used cautiously, especially if they have viral illnesses?

View answer and explanation
Question 9

For which patient group are there no antiemetic agents approved for safe use, requiring careful selection?

View answer and explanation
Question 10

Concurrent use of antiemetics with other CNS depressants like antidepressants and opioid analgesics can lead to what effect?

View answer and explanation
Question 11

When phenothiazines are used with antihypertensives, nitrates, or acute ingestion of alcohol, what potential adverse effect can occur?

View answer and explanation
Question 12

What should be assessed in a patient receiving antiemetics before and following administration?

View answer and explanation
Question 13

For patients with severe nausea and vomiting, what additional intervention may be required besides antiemetics?

View answer and explanation
Question 14

Which of the following is listed as a potential nursing diagnosis for a patient taking antiemetics?

View answer and explanation
Question 15

When administering an antiemetic for prophylactic purposes, how should the timing be determined?

View answer and explanation
Question 16

Which general measure is recommended for patients to decrease nausea?

View answer and explanation
Question 17

Due to the potential for drowsiness, what should a patient be advised to do while taking antiemetics?

View answer and explanation
Question 18

To minimize orthostatic hypotension, what instruction should be given to a patient taking antiemetics?

View answer and explanation
Question 19

What is the primary desired outcome for a patient receiving antiemetic therapy?

View answer and explanation
Question 20

Which specific group of antiemetics are used for nausea and vomiting associated with surgery, anesthesia, and antineoplastic therapy?

View answer and explanation
Question 21

What is the mechanism of action for dimenhydrinate, scopolamine, and meclizine as antiemetics?

View answer and explanation
Question 22

The interaction between phenothiazines and alcohol can lead to what adverse effect?

View answer and explanation
Question 23

Besides nausea and vomiting, what other two parameters are important to monitor in a patient receiving antiemetics?

View answer and explanation
Question 24

Which nursing diagnosis relates to the nutritional status of a patient taking antiemetics?

View answer and explanation
Question 25

What patient teaching point is related to managing the environment to decrease nausea?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations